71 related articles for article (PubMed ID: 21456504)
41. Immunohistochemical localisation of tenascin in invasive ductal carcinoma of the breast.
Tökés AM; Hortoványi E; Csordás G; Kulka J; Mózes G; Hatalyák A; Kádár A
Anticancer Res; 1999; 19(1A):175-9. PubMed ID: 10226540
[TBL] [Abstract][Full Text] [Related]
42. Promoter methylation of glutathione S-transferase pi1 and multidrug resistance gene 1 in bronchioloalveolar carcinoma and its correlation with DNA methyltransferase 1 expression.
Gao P; Yang X; Xue YW; Zhang XF; Wang Y; Liu WJ; Wu XJ
Cancer; 2009 Jul; 115(14):3222-32. PubMed ID: 19484794
[TBL] [Abstract][Full Text] [Related]
43. Benign proliferative lesions and in situ carcinoma of the breast: new immunohistological findings and their biological implications.
Böcker W; Bier B; Ludwig A; de Hesselle B; Gerdes J
Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():41-9. PubMed ID: 7507748
[No Abstract] [Full Text] [Related]
44. Gp96 and its different expression in breast carcinomas.
Hodorova I; Rybarova S; Solar P; Vecanova J; Prokopcakova L; Bohus P; Solarova Z; Mellova Y; Schmidtova K
Neoplasma; 2008; 55(1):31-5. PubMed ID: 18190237
[TBL] [Abstract][Full Text] [Related]
45. Fluorescein diacetate (FDA) and its analogue as substrates for Pi-class glutathione S-transferase (GSTP1) and their biological application.
Fujikawa Y; Nampo T; Mori M; Kikkawa M; Inoue H
Talanta; 2018 Mar; 179():845-852. PubMed ID: 29310316
[TBL] [Abstract][Full Text] [Related]
46. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma.
Shah C; Wilkinson JB; Shaitelman S; Grills I; Wallace M; Mitchell C; Vicini F
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e547-51. PubMed ID: 21640491
[TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical detection of metallothionein in primary breast carcinomas and their axillary lymph node metastases.
Haerslev T; Jacobsen K; Nedergaard L; Zedeler K
Pathol Res Pract; 1994 Aug; 190(7):675-81. PubMed ID: 7808966
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical demonstration of glutathione S-transferases in primary human breast carcinomas.
Cairns J; Wright C; Cattan AR; Hall AG; Cantwell BJ; Harris AL; Horne CH
J Pathol; 1992 Jan; 166(1):19-25. PubMed ID: 1347080
[TBL] [Abstract][Full Text] [Related]
49. Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1.
Nelson CP; Kidd LC; Sauvageot J; Isaacs WB; De Marzo AM; Groopman JD; Nelson WG; Kensler TW
Cancer Res; 2001 Jan; 61(1):103-9. PubMed ID: 11196146
[TBL] [Abstract][Full Text] [Related]
50. A highly selective fluorogenic substrate for imaging glutathione S-transferase P1: development and cellular applicability in epigenetic studies.
Mori M; Fujikawa Y; Kikkawa M; Shino M; Sawane M; Sato S; Inoue H
Chem Commun (Camb); 2019 Jul; 55(56):8122-8125. PubMed ID: 31237279
[TBL] [Abstract][Full Text] [Related]
51. Pi-Class Glutathione S-transferase (GSTP1)-Selective Fluorescent Probes for Multicolour Imaging with Various Cancer-Associated Enzymes.
Fujikawa Y; Mori M; Tsukada M; Miyahara S; Sato-Fukushima H; Watanabe E; Murakami-Tonami Y; Inoue H
Chembiochem; 2022 Nov; 23(21):e202200443. PubMed ID: 36062403
[TBL] [Abstract][Full Text] [Related]
52. Glutathione S-transferase pi isoform (GSTP1) expression in murine retina increases with developmental maturity.
Lee WH; Joshi P; Wen R
Adv Exp Med Biol; 2014; 801():23-30. PubMed ID: 24664677
[TBL] [Abstract][Full Text] [Related]
53. Ductal carcinoma of the breast in the pacemaker generator's pocket.
Zonca P; Herokova J; Cambal M; Jacobi CA
Bratisl Lek Listy; 2009; 110(11):719-22. PubMed ID: 20120443
[TBL] [Abstract][Full Text] [Related]
54. Netting into the Sophoretin pool: An approach to trace GSTP1 inhibitors for reversing chemoresistance.
Bhattacharya K; Mahato S; Deka S; Chanu NR; Shrivastava AK; Khanal P
Comput Biol Chem; 2024 Feb; 108():107981. PubMed ID: 37976621
[TBL] [Abstract][Full Text] [Related]
55. GSTP1 as a Potential Marker of Early Chemotherapy Response for Noninvasive Detection.
Izumchenko E; Shavit Grievink L; Rosenbaum E; Hoque MO
Eur Urol; 2019 Sep; 76(3):313-314. PubMed ID: 30642610
[No Abstract] [Full Text] [Related]
56. Evaluation of glutathione S-transferase pi 1 expression and gene promoter methylation in Moroccan patients with urothelial bladder cancer.
Hadami K; Dakka N; Bensaid M; El Ahanidi H; Ameur A; Chahdi H; Oukabli M; Al Bouzidi A; Attaleb M; El Mzibri M
Mol Genet Genomic Med; 2018 Sep; 6(5):819-827. PubMed ID: 30043549
[TBL] [Abstract][Full Text] [Related]
57. Identification of a novel Calotropis procera protein that can suppress tumor growth in breast cancer through the suppression of NF-κB pathway.
Samy RP; Rajendran P; Li F; Anandi NM; Stiles BG; Ignacimuthu S; Sethi G; Chow VT
PLoS One; 2012; 7(12):e48514. PubMed ID: 23284617
[TBL] [Abstract][Full Text] [Related]
58. Interaction between GSTP1 Val allele and H. pylori infection, smoking and alcohol consumption and risk of gastric cancer among the Chinese population.
Zhang Y; Sun LP; Xing CZ; Xu Q; He CY; Li P; Gong YH; Liu YP; Yuan Y
PLoS One; 2012; 7(10):e47178. PubMed ID: 23077566
[TBL] [Abstract][Full Text] [Related]
59. Immunohistochemical evaluation of Pi class glutathione S-transferase expression in invasive breast carcinoma.
Vecanova J; Hodorova I; Mihalik J; Benicky M; Kluchova D; Rybarova S
Bratisl Lek Listy; 2011; 112(2):67-70. PubMed ID: 21456504
[TBL] [Abstract][Full Text] [Related]
60. Glutathione S-transferase Pi expression in invasive breast cancer and its relation with the clinical outcome.
Franco RL; Schenka NG; Schenka AA; Rezende LF; Gurgel MS
J BUON; 2012; 17(2):259-64. PubMed ID: 22740203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
